CTI BioPharma Corp. (CTIC)

0.73
0.00 0.60
NASDAQ : Health Technology
Prev Close 0.73
Open 0.73
Day Low/High 0.73 / 0.74
52 Wk Low/High 0.60 / 1.76
Volume 30.26K
Avg Volume 100.40K
Exchange NASDAQ
Shares Outstanding 57.98M
Market Cap 42.33M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Thursday's Health Winners & Losers

Thursday's Health Winners & Losers

SonoSite climbs on a rise in quarterly sales.

Tuesday's Small-Cap Winners & Losers

Tuesday's Small-Cap Winners & Losers

Steak n Shake moves higher on news of a big shareholder investment.

Monday's Health Winners & Losers

Monday's Health Winners & Losers

Cholestech and Digene soar on respective merger news.

Real Story: Air of Forgiveness

Real Story: Air of Forgiveness

'Bad news' is mainly ignored as stocks rally, but Helene Meisler says sell the rallies. Plus, Joe Capone on subprime's winners.

Thursday's Health Winners & Losers

Thursday's Health Winners & Losers

Health care and biotech stocks were up, helped by gainers such as MedImmune.

Fed Minutes Slam Stocks

The central bank pulls the rug out from under the bulls. Plus, Cody Willard on Yahoo!, 'Should I Do It' emails and postclose results from Genentech and RIM.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

A slew of health care stocks such as Dendreon and Nuvelo dropped on analyst downgrades.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

Affymetrix is climbing.

Friday's Health Winners & Losers

Friday's Health Winners & Losers

CV Therapeutics is rising.

Cell Therapeutics Up on Study

A lymphoma drug appears to show promise.

Friday's Health Winners & Losers

Friday's Health Winners & Losers

Novacea slips on an executive change.

Cell Therapeutics Closing Trial

It plans to submit a new study design to regulators.

Cell Therapeutics Slips on Offering

Cell Therapeutics Slips on Offering

It raises $40 million but sends shares down 17%.

Cell Therapeutics Has New Pact

Cell Therapeutics Has New Pact

The deal could be worth $285 million.

Tuesday's Health Winners & Losers

Tuesday's Health Winners & Losers

Arena Pharmaceuticals is rising.

Thursday's Early Winners & Losers

Thursday's Early Winners & Losers

Creative surges after it signs a deal with Apple.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

Bristol-Myers is lower.

Drug Results Lift Cell Therapeutics

Drug Results Lift Cell Therapeutics

The company's shares surge 14%.

Tuesday's Health Winners and Losers

Tuesday's Health Winners and Losers

Investors in Inspire aren't inspired.

The Daily Blog Watch

The Daily Blog Watch

The latest numbers from Google, Microsoft's to-do list and cancer stock Cell Therapeutics.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

Cell Therapuetics moves higher after signing a financing deal with Societe Generale.

Kidney Drugs Take Stage

Kidney Drugs Take Stage

Pfizer and Wyeth show positive data in cancer trials at ASCO.

Today's Health Winners and Losers

Today's Health Winners and Losers

Corautus Genetics plunges after ending enrollment of its trial for an angina treatment.

Health Stocks in Motion

Health Stocks in Motion

Cell Therapeutics runs on trial results.

Cephalon Outlook Irks Investors

Cephalon Outlook Irks Investors

Second-quarter earnings beat estimates, but the forecast is weak.

Cell Therapeutics Sells Product to Cephalon

Cell Therapeutics Sells Product to Cephalon

Cephalon initially will pay $70 million for the Trisenox assets.

Cell Therapeutics Up on Xyotax

Shares jump 10% on positive news on its cancer drug.

Cell Therapeutics Upbeat on Xyotax Results

Cell Therapeutics Upbeat on Xyotax Results

Data from a study showed a major tumor response in 98% of first-line ovarian cancer patients.

Health Stocks in Motion

Corixa rises on Glaxo buyout.

Health Stocks in Motion

Health Stocks in Motion

Prana Biotechnology is hammered after halting a trial.

TheStreet Quant Rating: D (Sell)